Compounds > sofosbuvir
Page last updated: 2024-08-25

sofosbuvir and Mental Disorders

sofosbuvir has been researched along with Mental Disorders in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Acosta-López, S; Borgia, SM; Buti, M; Di Marco, V; Fenech, M; Fraser, C; Garcia-Retortillo, M; Guerra-Veloz, MF; Hernández, C; Martins, A; Mertens, M; Milella, M; Milligan, S; Morano Amado, LE; Ntalla, I; O'Loan, J; Ramji, A; Ramroth, H; Rodriguez-Tajes, S; Teti, E; Vanstraelen, K; Wedemeyer, H1
Brown, CH; Fang, LJ; Goldberg, R; Graydon, M; Himelhoch, S; Kreyenbuhl, J; Slade, E; Travaglini, LE1
Haley, SJ; Kreek, MJ1
Elsheikh, E; Estep, JM; Gerber, L; Golabi, P; Karrar, A; Stepanova, M; Younossi, I; Younossi, ZM1

Other Studies

4 other study(ies) available for sofosbuvir and Mental Disorders

ArticleYear
Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health Disorders.
    Viruses, 2022, 11-11, Volume: 14, Issue:11

    Topics: Antiviral Agents; Genotype; Hepacivirus; Hepatitis C; Humans; Mental Disorders; Sofosbuvir

2022
Access to Direct-Acting Antiviral Treatment for Hepatitis C Virus Among Veterans With Serious Mental Illness.
    Psychiatric services (Washington, D.C.), 2020, 02-01, Volume: 71, Issue:2

    Topics: Adult; Aged; Antiviral Agents; Female; Health Services Accessibility; Hepatitis C; Humans; Logistic Models; Male; Mental Disorders; Middle Aged; Sofosbuvir; Treatment Outcome; United States; United States Department of Veterans Affairs; Veterans

2020
A window of opportunity: maximizing the effectiveness of new HCV regimens in the United States with the expansion of the Affordable Care Act.
    American journal of public health, 2015, Volume: 105, Issue:3

    Topics: Adult; Antiviral Agents; Comorbidity; Drug Approval; Drug Therapy, Combination; Genotype; Health Services Accessibility; Hepatitis B; Hepatitis C, Chronic; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Insurance Coverage; Mental Disorders; Patient Protection and Affordable Care Act; Population Surveillance; Poverty; Prevalence; Risk Factors; Simeprevir; Sofosbuvir; Substance Abuse, Intravenous; Sulfonamides; United States; Uridine Monophosphate

2015
The levels of monoamine neurotransmitters and measures of mental and emotional health in HCV patients treated with ledipasvir (LDV) and sofosbuvir (SOF) with or without ribavirin (RBV).
    Medicine, 2016, Volume: 95, Issue:46

    Topics: Affective Symptoms; Antiviral Agents; Benzimidazoles; Biomarkers; Cytokines; Female; Fluorenes; Hepatitis C, Chronic; Humans; Male; Mental Disorders; Middle Aged; Neurotransmitter Agents; Retrospective Studies; Ribavirin; Sofosbuvir

2016